The report of the common IABS - EMAV meeting about Autogenous vaccines, held on 14-16 September in Munich, is available at the scientific journal BIOLOGICALS (Volume 76, April 2022, Pages 36-41)
Recently the IABS “Conclusion and Recommendation” of the Munich conference about “Autogenous Vaccines: quality of production and movement in a common market” have been published at the IABS congress website.
The European Affiliate of the International Alliance for Biological Standardization (IABS-EU) and the Association of European Manufacturers of Autogenous Vaccines & Sera (EMAV) have confirmed the Meeting “Autogenous Vaccines: Quality of Production and Movement in a Common Market” from the 14th to 16th of September, 2021 at Ludwig Maximilian University in Munich, Germany.
On 15th of March the EMAV members met for the first time using Zoom for an ordinary General Assembly and an EMAV Workshop ...
In several Workshop discussions EMAV members developed key elements of future manufacturing standards for autogenous vaccines ...